top of page
GRG's Center For Experiential Learning
Search
GLP-1 Agonists and Beyond: What’s Next in the Anti-Obesity Market?
The global fight against obesity is entering a revolutionary phase. With the advent of GLP-1 (glucagon-like peptide-1) receptor agonists...
4 min read
The Weight-Loss Revolution: Why Anti-Obesity Drugs Are Thriving This Year
In recent years, the global health landscape has witnessed a significant shift in the perception and management of obesity. Weight-loss...
5 min read
From Diabetes to Weight Loss: Ozempic's Dual Benefits
In recent years, the conversation around diabetes management has expanded beyond controlling blood sugar levels. With the rising...
5 min read
bottom of page